(2026). Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Surveillance of Hepatocellular Carcinoma (HCC) Patients Using Protein Induced by Vitamin K (PIVKA-II): A Cost-utility Analysis for Hong Kong."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Surveillance of Hepatocellular Carcinoma (HCC) Patients Using Protein Induced by Vitamin K (PIVKA-II): A Cost-utility Analysis for Hong Kong."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.